Palo Alto Investors LP - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203101. A total of 1 filers reported holding SOLENO THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Palo Alto Investors LP ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$220,000
+3.8%
84,748
-80.0%
0.01%
-10.0%
Q2 2017$212,000423,7380.01%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Vivo Capital, LLC 14,695,264$7,642,0001.54%
Palo Alto Investors LP 84,748$220,0000.01%
683 Capital Management, LLC 150,000$78,0000.01%
TWO SIGMA SECURITIES, LLC 44,230$23,0000.00%
Virtu Financial LLC 52,942$28,0000.00%
VANGUARD GROUP INC 202,427$105,0000.00%
NORTHERN TRUST CORP 14,376$7,0000.00%
ROYAL BANK OF CANADA 7$00.00%
UBS Group AG 16,718$9,0000.00%
GOLDMAN SACHS GROUP INC 10,170$5,0000.00%
View complete list of SOLENO THERAPEUTICS INC shareholders